Form D · Other Health Care
TMRW Life Sciences Holdings, LLC
New York, NY · CIK 0001759389
Offering snapshot reported Nov 21, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $12M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326364
Source: Form D, filed Nov 21, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Abram | Executive |
| Euclid Partners Llc | Executive |
| Alan Murray | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
160 Mercer Street 3 Rd Floor
New York, NY, 10012
New York, NY, 10012